In Today’s Masters in Trading: Live Last week, I told you about one under-the-radar sector poised for huge gains in 2026. Today, I'm revealing the next big sector we'll be gaining direct exposure to over the next year: biotech stocks. Biotech stocks are being thrust back in the spotlight as a whole wave of innovations in AI spark major overhauls in everything from drug discovery to diagnostic imaging. 2025 was the year this trend in biotech finally hit most traders’ radar. AI is providing the kerosene for biotech’s breakout. And a series of totally predictable catalysts is providing the spark that will ignite a whole wave of new opportunities for us in the new year. It all comes down to one calendar the entire biotech industry runs on like clockwork: the PDUFA Calendar. PDUFA stands for Prescription Drug User Fee Act. Basically, it tracks when the Food and Drug Administration makes decisions on new drugs. Think of it like earnings season but for biotech. Every time a PDUFA date hits, a biotech stock either soars or tanks based on whether the FDA approves their drug. Here's the best part: You know these dates months in advance. Advisory committees meet. They evaluate the drug. They vote. And the FDA almost always follows their recommendation. It's not a surprise. It's scheduled. Predictable. Over the next few months, we've got a wave of PDUFA dates coming. These cover everything from skin cancer treatments to digestive disease medications. And many of these companies are already getting massive government funding as AI makes their research faster and cheaper. We have AI rapidly overhauling the process of making life saving drugs. And with so many potential approvals lined up, we have a series of potential catalysts that could send any of my watch list picks surging higher. The best part? We don't need to wait that long to see some big moves in the space. They're already happening. I've got three stocks on my watchlist that could surge just as AI and new drug approvals catalyze the entire biotech sector. Just click here to watch my full breakdown for free. And stay tuned tomorrow. In the final video of this series, I’ll walk through my single favorite biotech trade going into 2026. You won’t want to miss this one. It’s the perfect trade to capitalize on biotech huge momentum throughout 2026. P.S. If you’re interested in learning more about how I discover picks like these every day… I recently revealed the details behind my winning strategy with these The Profit Surge Event. I showed exactly how I spot these opportunities before Wall Street catches on. And I even invited three of the best stock pickers in the business — Louis Navellier, Eric Fry, and Luke Lango — to share their highest-conviction plays. These are the names they're watching most closely right now. If you weren't able to join me for the live event, I'm offering a replay of the full webinar free for a limited time. Just click here to watch the full breakdown. 
| Recommended Link | | | | Master trader Jonathan Rose has built his incredible track record by exploiting Wall Street’s hidden bets for huge paydays. And he just found three new trades Wall Street is going all in on… Three trades he believes could each make you 500% or more before January ends. Watch this time-sensitive video to get the details. |  | |
Remember, the creative trader wins, | 
0 Response to "JR’s 2026 Predictions – The Biotech Boom of 2026: 3 Stocks to Watch"
Post a Comment